Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;131(10):107004.
doi: 10.1289/EHP12532. Epub 2023 Oct 5.

Characterization of Anxiety-Like Behaviors and Neural Circuitry following Chronic Moderate Noise Exposure in Mice

Affiliations

Characterization of Anxiety-Like Behaviors and Neural Circuitry following Chronic Moderate Noise Exposure in Mice

Xiaoqi Peng et al. Environ Health Perspect. 2023 Oct.

Abstract

Background: Commonly encountered nontraumatic, moderate noise is increasingly implicated in anxiety; however, the neural substrates underlying this process remain unclear.

Objectives: We investigated the neural circuit mechanism through which chronic exposure to moderate-level noise causes anxiety-like behaviors.

Methods: Mice were exposed to chronic, moderate white noise [85 decibel (dB) sound pressure level (SPL)], 4 h/d for 4 wk to induce anxiety-like behaviors, which were assessed by open field, elevated plus maze, light-dark box, and social interaction tests. Viral tracing, immunofluorescence confocal imaging, and brain slice patch-clamp recordings were used to characterize projections from auditory brain regions to the lateral amygdala. Neuronal activities were characterized by in vivo multielectrode and fiber photometry recordings in awake mice. Optogenetics and chemogenetics were used to manipulate specific neural circuitry.

Results: Mice chronically (4 wk) exposed to moderate noise (85 dB SPL, 4 h/d) demonstrated greater neuronal activity in the lateral amygdala (LA), and the LA played a critical role in noise-induced anxiety-like behavior in these model mice. Viral tracing showed that the LA received monosynaptic projections from the medial geniculate body (MG) and auditory cortex (ACx). Optogenetic excitation of the MGLA or ACxLA circuits acutely evoked anxiety-like behaviors, whereas their chemogenetic inactivation abolished noise-induced anxiety-like behavior. Moreover, mice chronically exposed to moderate noise were more susceptible to acute stress, with more neuronal firing in the LA, even after noise withdrawal.

Discussion: Mice exposed to 4 wk of moderate noise (85 dB SPL, 4 h/d) demonstrated behavioral and physiological differences compared to controls. The neural circuit mechanisms involved greater excitation from glutamatergic neurons of the MG and ACx to LA neurons under chronic, moderate noise exposure, which ultimately promoted anxiety-like behaviors. Our findings support the hypothesis that nontraumatic noise pollution is a potentially serious but unrecognized public health concern. https://doi.org/10.1289/EHP12532.

PubMed Disclaimer

Figures

Figure 1A is a timeline for noise exposure and behavioral tests. From day 0 to 1, habituation took place. Day 1 to 28, 4 hours with 85 decibels sound pressure level noise exposure per day were conducted. On day 28, open field tests per elevated plus maze were recorded. Below, a schematic diagram depicts the noise exposure in two sound-proof chambers. Figure 1B is a set of two waveform graphs titled control and noise under click-evoked auditory brainstem response waveforms, plotting decibels, ranging from 20 to 90 in increments of 10 (y-axis) across milliseconds (x-axis). Figures 1C, 1K, 1M are bar graphs, plotting auditory brainstem response threshold (decibel sound pressure level), ranging from 0 to 50 in increments of 10; cumulative duration in dark zone(second), ranging from 400 to 800 in increments of 100; social interaction index, ranging from 0.0 to 2.0 in increments of 0.5 (y-axis) across control and noise (x-axis). Figures 1D and 1G are heatmaps. On the top, the heatmap plots open field tests (y-axis) across control and noise (x-axis). At the bottom, the heatmap plots elevated plus maze (y-axis) across control and noise (x-axis). Figures 1E, 1F, 1H, 1I are line graphs, plotting time in center (seconds), ranging from 0 to 60 in increments of 10; time in open arms (seconds), ranging from 0 to 100 in increments of 20; total distance in open field tests (centimeter), ranging from 0 to 4000 in increments of 1000; total distance in elevated plus maze, ranging from 0 to 2000 in increments of 500 (y-axis) across weeks, including 1 week, 2 weeks, 3 weeks, and 4 weeks (x-axis) for control and noise. Figure 1J is a heatmap, plotting control and noise (y-axis) across dark and light (x-axis). Figure 1L is a heatmap, plotting control and noise (y-axis) across empty and social (x-axis).
Figure 1.
Experimental overview, auditory brainstem response and behavioral outcomes in mice exposed to white noise for 4 wk. The mice were exposed to 85 dB SPL white noise for 4 wk (4 h/d), and auditory brainstem responses were used to determine the hearing sensitivity, and OFT and EPM tests were used to examine anxiety-like behaviors. (A) Timeline for noise exposure and behavioral tests (top) and schematic for noise exposure in a sound-proof chamber (bottom). (B) Representative waveforms for ABR evoked by click stimuli at different sound pressure levels in 10 dB steps. (C) Summarized data for click-evoked ABR thresholds (U=17, p=0.9740). (D) The representative heatmaps for moving trajectory in OFT (top) and EPM (bottom). (E and F) Summarized data for time spent in the center of the OFT (E, 1W, t(14)=0.5916, p=0.5635; 2W, U=20, p=0.3132; 3W, U=5, p=0.0047; 4W, t(14)=12.36, p<0.0001), and in the open arms of the EPM (F, 1W, t(11)=0.3527, p=0.731; 2W, U=10, p=0.1375; 3W, t(11)=3.185, p=0.0087; 4W, t(11)=6.040, p<0.0001) at different time points of noise exposure. (G) Representative path tracks in OFT (top) and EPM (bottom). (H and I) Summarized data for the total travel distance in the OFT (H, 1W, t(14)=0.3454, p=0.7350; 2W, t(14)=0.2046, p=0.8408; 3W, t(14)=0.3555, p=0.7275; 4W, t(14)=0.1598, p=0.8753), and the EPM (I, 1W, t(11)=0.3425, p=0.7384; 2W, t(11)=0.4941, p=0.6310; 3W, t(11)=0.7119, p=0.4913; 4W, t(11)=0.3190, p=0.7557) at different time points during the four treatment period. (J and K) Representative heatmaps of track paths in light–dark box test (J) and summarized data for time spent in the dark side (K, t(17)=14.38, p<0.0001). (L and M) Representative heatmaps of track paths in the social interaction tests (L) and summarized data for interaction time with stranger mice (M, t(17)=5.775, p<0.0001). The data are expressed as the mean±SEM. **p<0.01; ***p<0.001. Two-way ANOVA analysis for (H) and (I). Unpaired Student’s t-test for 1W and 4 W in (E), (F), (H), (I), (K) and (M). Mann-Whitney U-test for (C), 2W and 3W in (E), and (F). For (C) n=6 control mice, 6 noise mice. For (E) n=6 control mice, 10 noise mice. For (F) n=6 control mice, 7 noise mice. For (H) n=6 control mice, 10 noise mice. For (I) n=6 control mice, 7 noise mice. For (K) n=9 control mice, 10 noise mice. For (M) n=9 control mice, 10 noise mice. The numerical data underlying this figure are shown in Excel Tables S1–S2. Note: ABR, auditory brainstem response; ANOVA, analysis of variance; dB, decibel; EPM, elevated plus maze; NS, not significant; OFT, open-field tests; SEM, standard error of the mean; SPL, sound pressure level.
Figure 1A is a timeline for noise exposure and behavioral tests. From day 0 to 1, habituation took place. Day 1 to 28, 4 hours with 85 decibels sound pressure level noise exposure per day were conducted. On day 28, open field tests per elevated plus maze were recorded. Below, a schematic diagram depicts the noise exposure in two sound-proof chambers. Figure 1B is a set of two waveform graphs titled control and noise under click-evoked auditory brainstem response waveforms, plotting decibels, ranging from 20 to 90 in increments of 10 (y-axis) across milliseconds (x-axis). Figures 1C, 1K, 1M are bar graphs, plotting auditory brainstem response threshold (decibel sound pressure level), ranging from 0 to 50 in increments of 10; cumulative duration in dark zone(second), ranging from 400 to 800 in increments of 100; social interaction index, ranging from 0.0 to 2.0 in increments of 0.5 (y-axis) across control and noise (x-axis). Figures 1D and 1G are heatmaps. On the top, the heatmap plots open field tests (y-axis) across control and noise (x-axis). At the bottom, the heatmap plots elevated plus maze (y-axis) across control and noise (x-axis). Figures 1E, 1F, 1H, 1I are line graphs, plotting time in center (seconds), ranging from 0 to 60 in increments of 10; time in open arms (seconds), ranging from 0 to 100 in increments of 20; total distance in open field tests (centimeter), ranging from 0 to 4000 in increments of 1000; total distance in elevated plus maze, ranging from 0 to 2000 in increments of 500 (y-axis) across weeks, including 1 week, 2 weeks, 3 weeks, and 4 weeks (x-axis) for control and noise. Figure 1J is a heatmap, plotting control and noise (y-axis) across dark and light (x-axis). Figure 1L is a heatmap, plotting control and noise (y-axis) across empty and social (x-axis).
Figure 1.
Experimental overview, auditory brainstem response and behavioral outcomes in mice exposed to white noise for 4 wk. The mice were exposed to 85 dB SPL white noise for 4 wk (4 h/d), and auditory brainstem responses were used to determine the hearing sensitivity, and OFT and EPM tests were used to examine anxiety-like behaviors. (A) Timeline for noise exposure and behavioral tests (top) and schematic for noise exposure in a sound-proof chamber (bottom). (B) Representative waveforms for ABR evoked by click stimuli at different sound pressure levels in 10 dB steps. (C) Summarized data for click-evoked ABR thresholds (U=17, p=0.9740). (D) The representative heatmaps for moving trajectory in OFT (top) and EPM (bottom). (E and F) Summarized data for time spent in the center of the OFT (E, 1W, t(14)=0.5916, p=0.5635; 2W, U=20, p=0.3132; 3W, U=5, p=0.0047; 4W, t(14)=12.36, p<0.0001), and in the open arms of the EPM (F, 1W, t(11)=0.3527, p=0.731; 2W, U=10, p=0.1375; 3W, t(11)=3.185, p=0.0087; 4W, t(11)=6.040, p<0.0001) at different time points of noise exposure. (G) Representative path tracks in OFT (top) and EPM (bottom). (H and I) Summarized data for the total travel distance in the OFT (H, 1W, t(14)=0.3454, p=0.7350; 2W, t(14)=0.2046, p=0.8408; 3W, t(14)=0.3555, p=0.7275; 4W, t(14)=0.1598, p=0.8753), and the EPM (I, 1W, t(11)=0.3425, p=0.7384; 2W, t(11)=0.4941, p=0.6310; 3W, t(11)=0.7119, p=0.4913; 4W, t(11)=0.3190, p=0.7557) at different time points during the four treatment period. (J and K) Representative heatmaps of track paths in light–dark box test (J) and summarized data for time spent in the dark side (K, t(17)=14.38, p<0.0001). (L and M) Representative heatmaps of track paths in the social interaction tests (L) and summarized data for interaction time with stranger mice (M, t(17)=5.775, p<0.0001). The data are expressed as the mean±SEM. **p<0.01; ***p<0.001. Two-way ANOVA analysis for (H) and (I). Unpaired Student’s t-test for 1W and 4 W in (E), (F), (H), (I), (K) and (M). Mann-Whitney U-test for (C), 2W and 3W in (E), and (F). For (C) n=6 control mice, 6 noise mice. For (E) n=6 control mice, 10 noise mice. For (F) n=6 control mice, 7 noise mice. For (H) n=6 control mice, 10 noise mice. For (I) n=6 control mice, 7 noise mice. For (K) n=9 control mice, 10 noise mice. For (M) n=9 control mice, 10 noise mice. The numerical data underlying this figure are shown in Excel Tables S1–S2. Note: ABR, auditory brainstem response; ANOVA, analysis of variance; dB, decibel; EPM, elevated plus maze; NS, not significant; OFT, open-field tests; SEM, standard error of the mean; SPL, sound pressure level.
Figure 2A is a schematic diagram depicting the fiber photometry recording in the lateral amygdala. In the diagram, inside the lens, a laser beam passed through the green fluorescence protein filter reaches the photomultiplier tube. Figure 2B is a schematic diagram of adeno-associated virus-green fluorescent protein-based genetically encoded calcium indicator viral injections and optical fiber implantation in the lateral amygdala. Figure 2C is a heatmap titled lateral amygdala, plotting control and noise (y-axis) across time (second), ranging from negative 2 to 0 in increments of 2 and 0 to 10 in increments of 5 (x-axis). A scale ranges from negative 4 to 0 in increments of 4 and 0 to 12 in increments of 12. Figure 2D is a ribbon plus line graph, plotting uppercase delta fluorescence intensity over fluorescence intensity (percentage), ranging from negative 2 to 10 in increments of 2 (y-axis) across time (second), ranging from negative 2 to 0 in increments of 2 and 0 to 10 in increments of 5 (x-axis) for control and noise. Figure 2E is a schematic diagram depicting the extracellular recordings using a silicon probe in head-fixed mice. There is a rotatory table with a head-fixed mouse. A headstage silicon probe with a micromanipulator and amplifier. Figure 2F is a set of two graph. The two graphs plot noise and control (y-axis) across firing rate (hertz), ranging from 0 to 10 in increments of 2 (x-axis). Figure 2G is a sample of current traces of miniature excitatory postsynaptic currents that were recorded in lateral amygdala neurons of control and noise-treated mice. Figures 2H, 2I, 2K, 2L, 2O, 2P, 2Q, 2R are bar graphs, plotting miniature excitatory postsynaptic currents frequency (hertz), ranging from 0 to 40 in increments of 10; miniature excitatory postsynaptic currents amplitude (picoampere), ranging from 0 to 30 in increments of 10; miniature inhibitory postsynaptic currents frequency (hertz), ranging from 0 to 6 in increments of 2; miniature inhibitory postsynaptic currents amplitude (pascal), ranging from 0 to 50 in increments of 10; firing rate (hertz), ranging from 0 to 6 in increments of 2; time in center (second), ranging from 0 to 80 in increments of 20; total distance (centimeter), ranging from 0 to 5000 in increments of 1000; time in open arms (second), ranging from 0 to 100 in increments of 20 (y-axis) across control and noise; control and noise; control and noise; control and noise; baseline, muscimol, saline; saline and muscimol; saline and muscimol; saline and muscimol (x-axis). Figure 2J is a sample of current traces of miniature inhibitory postsynaptic currents that were recorded in lateral amygdala neurons of control and noise-treated mice. Figure 2M is a schematic diagram depicting the coronal brain slice that displays the cannula tracks above the lateral amygdala, and the timeline from day 0 to day 28 depicts the noise exposure, chemical inactivation, and behavioral tests, including saline or muscimol. Figure 2N is a sample of the typical voltage traces recorded in the lateral amygdala following local application of baseline, muscimol, and saline.
Figure 2.
Calcium signals, spontaneous firing, synaptic transmission in the LA of noise-exposed mice, and behavioral effects of LA chemical inactivation. In vivo fiber photometry, silicon probe extracellular recordings, and in vitro brain slice patch-clamp recordings were used to investigate the LA neuronal activity and synaptic transmission. Observations of elevated excitability in the LA led us to investigate whether blocking LA activity could abolish noise-evoked anxiety-like behaviors. (A) Schematic for fiber photometry recording in the LA. (B) Schematic (top) and typical image (bottom) of AAV-GCaMP6m viral injection and optical fiber implantation in the LA. Scale bars: 200μm. (C) Heatmap of LAGlu GCaMP6m calcium signals evoked by white noise (100-ms duration, 85 dB SPL). (D) Averaged traces for ΔF/F of LAGlu GCaMP6m signals. (E) Schematic for extracellular recordings using a silicon probe in head-fixed mice. (F) Representative voltage traces (top) and summarized data (bottom) of spontaneous firings recorded in the LA (U=165, p=0.0004). (G) Sample current traces of mEPSCs recorded in LA neurons of control and noise-treated mice. (H and I) Summarized data for the frequency (H, t(26)=3.565, p=0.0014) and amplitude (I, t(26)=1.084, p=0.2882) of the mEPSCs. (J) Sample current traces of mIPSCs recorded in LA neurons of control and noise-treated mice. (K and L) Summarized data for the frequency (K, t(16)=2.756, p=0.0141) and amplitude (L, t(16)=2.517, p=0.0229) of the mIPSCs. (M) Representative image of a coronal brain slice showing cannula tracks above the LA (top) and the timeline for noise exposure, chemical inactivation, and behavioral tests. Scale bars: 500μm. (N and O) Typical voltage traces recorded in the LA following local application of muscimol or saline (N) and summarized data for spontaneous firing rates in naive mice (O, saline vs. muscimol, U=4, p<0.0001; Baseline vs. saline, t(19)=0.1078, p=0.9153). (P–R) Summarized data for time spent in center (P, t(16)=2.701, p=0.0158) and total travel distance (Q, t(16)=0.0002, p=0.9999) in the OFT, and time in open arms of EPM (R, t(18)=3.168, p=0.0053) in noise-exposed mice treated with muscimol or saline. The data are expressed as the mean±SEM. *p<0.05; **P<0.01; ***P<0.001. Unpaired t-test for (H), (I), (K), (L); Baseline vs. saline in (O), (P), (Q), and (R). Mann-Whitney U-test for (F) and saline vs. muscimol in (O). For (F) n=23 control cells, 32 noise cells. For (H) n=14 control cell, 14 noise cells. For (I) n=14 control cells, 14 noise cells. For (K) n=9 control cells, 9 noise cells; For (L) n=9 control cells, 9 noise cells. For (O) n=10 baseline cells, 11 saline cells, 11 muscimol cells. For (P) n=9 saline mice, 9 muscimol mice. For (Q) n=9 saline mice, 9 muscimol mice. For (R) n=10 saline mice, 10 muscimol mice. The numerical data underlying this figure are shown in Excel Tables S1–S3. Note: AAV, adeno-associated virus; ANOVA, analysis of variance; CaMKII, calcium-calmodulin (CaM)-dependent protein kinase II; dB SPL, decibel sound pressure level; EPM, elevated plus maze; GCaMP6m, green fluorescent protein-based genetically encoded calcium indicator; LA, lateral amygdala; LAGlu, lateral amygdala glutamatergic neurons; mEPSC, miniature excitatory postsynaptic currents; mIPSCs, miniature inhibitory postsynaptic currents; OFT, open-field tests; NS, not significant; SEM, standard error of the mean.
Figure 2A is a schematic diagram depicting the fiber photometry recording in the lateral amygdala. In the diagram, inside the lens, a laser beam passed through the green fluorescence protein filter reaches the photomultiplier tube. Figure 2B is a schematic diagram of adeno-associated virus-green fluorescent protein-based genetically encoded calcium indicator viral injections and optical fiber implantation in the lateral amygdala. Figure 2C is a heatmap titled lateral amygdala, plotting control and noise (y-axis) across time (second), ranging from negative 2 to 0 in increments of 2 and 0 to 10 in increments of 5 (x-axis). A scale ranges from negative 4 to 0 in increments of 4 and 0 to 12 in increments of 12. Figure 2D is a ribbon plus line graph, plotting uppercase delta fluorescence intensity over fluorescence intensity (percentage), ranging from negative 2 to 10 in increments of 2 (y-axis) across time (second), ranging from negative 2 to 0 in increments of 2 and 0 to 10 in increments of 5 (x-axis) for control and noise. Figure 2E is a schematic diagram depicting the extracellular recordings using a silicon probe in head-fixed mice. There is a rotatory table with a head-fixed mouse. A headstage silicon probe with a micromanipulator and amplifier. Figure 2F is a set of two graph. The two graphs plot noise and control (y-axis) across firing rate (hertz), ranging from 0 to 10 in increments of 2 (x-axis). Figure 2G is a sample of current traces of miniature excitatory postsynaptic currents that were recorded in lateral amygdala neurons of control and noise-treated mice. Figures 2H, 2I, 2K, 2L, 2O, 2P, 2Q, 2R are bar graphs, plotting miniature excitatory postsynaptic currents frequency (hertz), ranging from 0 to 40 in increments of 10; miniature excitatory postsynaptic currents amplitude (picoampere), ranging from 0 to 30 in increments of 10; miniature inhibitory postsynaptic currents frequency (hertz), ranging from 0 to 6 in increments of 2; miniature inhibitory postsynaptic currents amplitude (pascal), ranging from 0 to 50 in increments of 10; firing rate (hertz), ranging from 0 to 6 in increments of 2; time in center (second), ranging from 0 to 80 in increments of 20; total distance (centimeter), ranging from 0 to 5000 in increments of 1000; time in open arms (second), ranging from 0 to 100 in increments of 20 (y-axis) across control and noise; control and noise; control and noise; control and noise; baseline, muscimol, saline; saline and muscimol; saline and muscimol; saline and muscimol (x-axis). Figure 2J is a sample of current traces of miniature inhibitory postsynaptic currents that were recorded in lateral amygdala neurons of control and noise-treated mice. Figure 2M is a schematic diagram depicting the coronal brain slice that displays the cannula tracks above the lateral amygdala, and the timeline from day 0 to day 28 depicts the noise exposure, chemical inactivation, and behavioral tests, including saline or muscimol. Figure 2N is a sample of the typical voltage traces recorded in the lateral amygdala following local application of baseline, muscimol, and saline.
Figure 2.
Calcium signals, spontaneous firing, synaptic transmission in the LA of noise-exposed mice, and behavioral effects of LA chemical inactivation. In vivo fiber photometry, silicon probe extracellular recordings, and in vitro brain slice patch-clamp recordings were used to investigate the LA neuronal activity and synaptic transmission. Observations of elevated excitability in the LA led us to investigate whether blocking LA activity could abolish noise-evoked anxiety-like behaviors. (A) Schematic for fiber photometry recording in the LA. (B) Schematic (top) and typical image (bottom) of AAV-GCaMP6m viral injection and optical fiber implantation in the LA. Scale bars: 200μm. (C) Heatmap of LAGlu GCaMP6m calcium signals evoked by white noise (100-ms duration, 85 dB SPL). (D) Averaged traces for ΔF/F of LAGlu GCaMP6m signals. (E) Schematic for extracellular recordings using a silicon probe in head-fixed mice. (F) Representative voltage traces (top) and summarized data (bottom) of spontaneous firings recorded in the LA (U=165, p=0.0004). (G) Sample current traces of mEPSCs recorded in LA neurons of control and noise-treated mice. (H and I) Summarized data for the frequency (H, t(26)=3.565, p=0.0014) and amplitude (I, t(26)=1.084, p=0.2882) of the mEPSCs. (J) Sample current traces of mIPSCs recorded in LA neurons of control and noise-treated mice. (K and L) Summarized data for the frequency (K, t(16)=2.756, p=0.0141) and amplitude (L, t(16)=2.517, p=0.0229) of the mIPSCs. (M) Representative image of a coronal brain slice showing cannula tracks above the LA (top) and the timeline for noise exposure, chemical inactivation, and behavioral tests. Scale bars: 500μm. (N and O) Typical voltage traces recorded in the LA following local application of muscimol or saline (N) and summarized data for spontaneous firing rates in naive mice (O, saline vs. muscimol, U=4, p<0.0001; Baseline vs. saline, t(19)=0.1078, p=0.9153). (P–R) Summarized data for time spent in center (P, t(16)=2.701, p=0.0158) and total travel distance (Q, t(16)=0.0002, p=0.9999) in the OFT, and time in open arms of EPM (R, t(18)=3.168, p=0.0053) in noise-exposed mice treated with muscimol or saline. The data are expressed as the mean±SEM. *p<0.05; **P<0.01; ***P<0.001. Unpaired t-test for (H), (I), (K), (L); Baseline vs. saline in (O), (P), (Q), and (R). Mann-Whitney U-test for (F) and saline vs. muscimol in (O). For (F) n=23 control cells, 32 noise cells. For (H) n=14 control cell, 14 noise cells. For (I) n=14 control cells, 14 noise cells. For (K) n=9 control cells, 9 noise cells; For (L) n=9 control cells, 9 noise cells. For (O) n=10 baseline cells, 11 saline cells, 11 muscimol cells. For (P) n=9 saline mice, 9 muscimol mice. For (Q) n=9 saline mice, 9 muscimol mice. For (R) n=10 saline mice, 10 muscimol mice. The numerical data underlying this figure are shown in Excel Tables S1–S3. Note: AAV, adeno-associated virus; ANOVA, analysis of variance; CaMKII, calcium-calmodulin (CaM)-dependent protein kinase II; dB SPL, decibel sound pressure level; EPM, elevated plus maze; GCaMP6m, green fluorescent protein-based genetically encoded calcium indicator; LA, lateral amygdala; LAGlu, lateral amygdala glutamatergic neurons; mEPSC, miniature excitatory postsynaptic currents; mIPSCs, miniature inhibitory postsynaptic currents; OFT, open-field tests; NS, not significant; SEM, standard error of the mean.
Figure 3A is a schematic diagram depicting the viral injection and optogenetics and a typical image showing the optical fiber track above the adeno-associated virus-calmodulin-dependent protein kinase 2-channelrhodopsin-2-mCherry-expressing lateral amygdala with 472 nanometers of light. Figure 3B is a set of two sample traces of action potentials evoked by 473 nanometers of light, including 10 and 20 hertz, that were recorded in channelrhodopsin-2-positive lateral amygdala neurons in acute brain slices. Figures 3C, 3D, 3G, 3H are bar graphs, plotting time in center (second), ranging from 0 to 60 in increments of 20; time in open arms (second), ranging 0 to 150 in increments of 50; time in center (second), ranging from 0 to 50 in increments of 10; time in open arms (second), ranging from 0 to 100 in increments of 20 (y-axis) across mCherry and channelrhodopsin-2; mCherry and channelrhodopsin-2; mCherry and human M3 muscarinic receptor; and mCherry and human M3 muscarinic receptor (x-axis) for pre, light, saline, and clozapine-N-oxide. Figure 3E is a schematic diagram depicting the bilateral viral injection for chemogenetic experiments, including the adeno-associated virus-calmodulin-dependent protein kinase 2-channelrhodopsin-2-mCherry. Figure 3E is a line graph, plotting uppercase delta volt (millivolt), ranging from negative 2 to 8 in increments of 2 (y-axis) across 10 micromolar clozapine-N-oxide (x-axis) for mCherry and human M3 muscarinic receptor. A scale depicts the time (minute) ranges from 0 to 5 in unit increments.
Figure 3.
Electrophysiological recording and behavioral tests in mice with optogenetic or chemogenetic activation of the LA. To investigate the role of the LA in noise-evoked anxiety, neuronal activity in the LA was optogenetically or chemogenetically activated by direct injection of the LA with AAV-CaMKII-ChR2 or AAV-CaMKII-hM4Di viruses in C57 BL/6 mice. Brain slice recordings were used to validate the expression of each transfected virus, and anxiety-like behaviors were examined by OFT and EPM tests following optogenetic or chemogenetic manipulation of the LA. (A) Schematic for viral injection and optogenetics (top) and a typical image showing the optical fiber track above the mCherry-expressing LA (bottom). Scale bars: 200μm. (B) Sample traces of action potentials evoked by 473 nm light (blue bars) recorded in ChR2-positive LA neurons in acute brain slices. (C and D) Summarized data for time spent in the center (C, virus×light interaction, F(1,21)=36.12, p<0.0001; main effect of light, F(1,21)=27.10, p<0.0001) of the OFT and in the open arms of the EPM (D, virus×light interaction, F(1,18)=37.34, p<0.0001; main effect of light, F(1,18)=27.60, p<0.0001) before (pre) and during (light) light stimulation. (E) Schematic for bilateral viral injection for chemogenetic experiments. (F) Change in membrane potential in response to CNO perfusion (time×virus interaction, F(10,66)=3.913, p=0.0003; main effect of virus, F(1,66)=116.1, p<0.0001). (G and H) Summarized data for time spent in the center (G, virus×drug interaction, F(1,20)=8.741, p=0.0078; main effect of drug, F(1,20)=4.657, p=0.0433) of the OFT and in the open arms of the EPM (H, virus×drug interaction, F(1,20)=13.26, p=0.0016; main effect of drug, F(1,20)=13.11, P=0.0017) in mice treated with CNO or saline. The data are expressed as the mean±SEM. **p<0.01; ***p<0.001. Two-way ANOVA with Bonferroni post hoc analysis for (C), (D), (F), (G), and (H). For (C) n=11 mCherry mice, 12 ChR2 mice. For (D) n=10 mCherry mice, 10 ChR2 mice. For (F) n=4 mCherry cells, 4 hM3Dq cells. For (G) n=6 mCherry mice, 6 hM3Dq mice. For (H) n=6 mCherry mice, 6 hM3Dq mice. The numerical data underlying this figure are shown in Excel Tables S1 and S3. Note: AAV, adeno-associated virus; ANOVA, analysis of variance; ChR2, channelrhodopsin-2; CNO, clozapine-N-oxide; EPM, elevated plus maze; hM3Dq, human M3 muscarinic receptor; LA, lateral amygdala; OFT, open-field tests; NS, not significant; Pre, before light stimulation; SEM, standard error of the mean.
Figure 4A is schematic diagram depicting the viral injection for retrograde tracing, including adeno-associated virus per retro enhanced green fluorescent protein, auditory cortex, medial geniculate body, and lateral amygdala. Figure 4B is a virally infected tissue that depicts the successful viral injection in the amygdala, lateral amygdala, and basolateral amygdala. Figure 4C is a schematic diagram depicting the retrogradely traced neurons in the auditory thalamus in the medial geniculate body. Figures 4D and 4G are stained tissues that display cell type identification of traced enhanced green fluorescent protein-positive medial geniculate body neurons, where the most traced neurons were immunoreactive to antibodies against glutamate but none to antibodies against gamma-aminobutyric acid. Figures 4E, 4H, 4L, 4Q are bar graphs, cell (percentage), ranging from 0 to 100 in increments of 20; cell (percentage), ranging from 0 to 100 in increments of 20; cell (percentage), ranging from 0 to 100 in increments of 20; light-evoked excitatory postsynaptic currents (nanoampere), ranging from 0.0 to 1.5 in increments of 0.5 (y-axis) across glutamate and gamma-aminobutyric acid; glutamate and gamma-aminobutyric acid; glutamate and gamma-aminobutyric acid, each under enhanced green fluorescent protein and mCherry; and medial geniculate body with lateral amygdala and auditory cortex with lateral amygdala (x-axis). Figure 4I is a schematic diagram depicting the tracing strategy using a cyclization recombinase- locus of X(cross)-over in P 1) system to dissect the auditory cortex with lateral amygdala circuit and an flippase recombination enzyme-flp recognition target system to dissect the medial geniculate body with lateral amygdala circuit. Figure 4J is a virally traced tissue displays depicting the images of anterogradely traced lateral amygdala neurons in the enhanced yellow fluorescent protein postsynaptic to medial geniculate body projection fibers and those in mCherry postsynaptic to auditory cortex fibers. Figure 4K is a stained tissue depicting the images that displays predominant co-localization of traced fluorescent neurons with glutamate immunofluorescence signals, but few co-localization with gamma-aminobutyric acid immunofluorescence signals in the lateral amygdala. Figure 4M is a schematic diagram depicting the whole-cell recordings combined with optogenetics with adeno-associated virus-calmodulin-dependent protein kinase 2-channelrhodopsin-2-mCherry and 473 nanometers of light in the lateral amygdala with medial geniculate body fibers expressing channelrhodopsin-2. Figure 4N displays sample traces of action potentials in current-clamp mode with 50 millivolts in 100 milliseconds and postsynaptic currents in voltage-clamp mode evoked by a series of 473 nanometers of light stimuli in the lateral amygdala with medial geniculate body fibers expressing channelrhodopsin-2. Figure 4O is a schematic diagram depicting the whole-cell recordings combined with optogenetics with adeno-associated virus-calmodulin-dependent protein kinase 2-channelrhodopsin-2-mCherry and 473 nanometers of light in the lateral amygdala with auditory cortex fibers expressing channelrhodopsin-2. Figure 4P displays sample traces of action potentials in current-clamp mode with 50 millivolts in 100 milliseconds and postsynaptic currents in voltage-clamp mode evoked by a series of 473 nanometers light stimuli of auditory cortex fibers within lateral amygdala. Figure 4R is a set of one schematic diagram and one bar graph. The schematic diagram depicts the sample current traces of light-evoked excitatory postsynaptic currents recorded and of light-evoked inhibitory postsynaptic currents recorded by illuminating the medial geniculate body fibers within lateral amygdala. The bar denotes light, and the arrowhead denotes the beginning of light-evoked postsynaptic currents. The bar graph, plotting latency (millisecond), ranging from 0 to 15 in increments of 5 (y-axis) across excitatory postsynaptic currents and inhibitory postsynaptic currents (x-axis). Figure 4S is a set of one schematic diagram and one bar graph. The schematic diagram depicts the sample current traces of light-evoked excitatory postsynaptic currents recorded and of light-evoked inhibitory postsynaptic currents recorded by illuminating the auditory cortex projection fibers within lateral amygdala. The bar denotes light, and the arrowhead denotes the beginning of light-evoked postsynaptic currents. The bar graph, plotting latency (millisecond), ranging from 0 to 15 in increments of 5 (y-axis) across excitatory postsynaptic currents and inhibitory postsynaptic currents (x-axis). Figure 4T is a schematic diagram depicting the delivery of auditory monosynaptic excitation and di-synaptic inhibition to the lateral amygdala, including glutamate, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, gamma-aminobutyric acid, and gamma-aminobutyric acid type A receptors.
Figure 4.
Viral tracing and patch-clamp recording for morphological and functional characterization of auditory inputs to the LA. Retrograde viral tracing at the LA was used to identify auditory brain regions with LA-projecting neurons, and anterograde viral tracing at these auditory nuclei was performed to morphologically confirm the connections; functional synapses were examined using electrophysiological recordings and optogenetic stimulation in brain slices. (A) Schematic of viral injection for retrograde tracing. (B) Representative image of a successful viral injection in the LA. Scale bars: 500μm. (C) Retrogradely traced neurons in the auditory thalamus. Scale bars: 500μm. (D) Cell type identification of traced EGFP-positive MG neurons; most traced neurons were immunoreactive to antibody against glutamate (top) but none to antibody against GABA (bottom). Scale bars: 20μm. (E) The percentage of glutamate and GABA neurons among the traced EGFP-positive MG neurons. (F) The retrogradely traced neurons in the temporal regions. Scale bars: 500μm. (G) Cell type identification of traced EGFP-positive ACx neurons; most traced neurons were immunoreactive to the antibody for glutamate (top) but few to the antibody for GABA (bottom). Scale bars: 20μm. (H) The percentage of glutamate-positive and GABA-positive neurons among the traced EGFP-positive ACx neurons. (I) Tracing strategy using a Cre-loxP system to dissect the ACxLA circuit and an Flp-FRT system to dissect the MGLA circuit. (J) Representative images of anterogradely traced LA neurons (green, EYFP) postsynaptic to MG projection fibers and those (red, mCherry) postsynaptic to ACx fibers. Scale bars: 100μm. (K) Typical images showing predominant co-localization of traced fluorescent neurons with glutamate immunofluorescence signals but few co-localizations with GABA immunofluorescence signals in the LA. Scale bars: 20μm. (L) The percentage of EYFP-positive cells or mCherry-positive cells containing glutamate or GABA in the LA. (M) Schematic for whole-cell recordings combined with optogenetics. (N) Sample traces of action potentials (top, current-clamp mode) and postsynaptic currents (bottom, voltage-clamp mode) evoked by a series of 473 nm light (blue bars) stimuli of MGLA fibers. (O) Schematic for whole-cell recordings combined with optogenetics. (P) Sample traces of action potentials (top, current-clamp mode) and postsynaptic currents (bottom, voltage-clamp mode) evoked by a series of 473 nm light (blue bars) stimuli of ACxLA fibers. (Q) Quantification of light-evoked EPSCs. (R) Sample current traces of light-evoked EPSCs recorded at a holding potential of 70 mV and of light-evoked IPSCs recorded at a holding potential of 0 mV by illuminating MGLA fibers (left), and quantification of the latency for light-evoked EPSCs and IPSCs (right, t(18)=19.03, p<0.0001). The blue bar denotes 473 nm light, and the arrowhead denotes the beginning of light-evoked postsynaptic currents. (S) Sample current traces of light-evoked EPSCs recorded at a holding potential of 70 mV and of light-evoked IPSCs recorded at a holding potential of 0 mV (left) generated by illuminating ACxLA projection fibers, and quantification of the latency of light-evoked EPSCs and IPSCs (right, t(18)=9.504, p<0.0001). The blue bar denotes 473 nm light, and the arrowhead denotes the beginning of light-evoked postsynaptic currents. (T) Schematic diagram showing delivery of auditory monosynaptic excitation and di-synaptic inhibition to the LA. The data are expressed as the mean±SEM. ***p<0.001. Unpaired Student’s t-test for (R) and (S). For (E) n=5 slices from 3 mice (glutamate), 6 slices from 3 mice (GABA). For (H) n=10 slices from 3 mice (glutamate), 9 slices from 3 mice (GABA). For (L) n=6 slices from 3 mice (EGFP+ and glutamate+), 6 slices from 3 mice (EYFP+ and GABA+), 6 slices from 3 mice (mCherry+ and glutamate+), 6 slices from 3 mice (mCherry+ and GABA+). For (Q) n=14 cells (MGLA), 14 cells (ACxLA). For (R) n=10 cells (EPSC), 10 cells (IPSC). For (S) n=10 cells (EPSC), 10 cells (IPSC). The numerical data underlying this figure are shown in Excel Tables S3–S4. Note: AAV, adeno-associated virus; ACSF, artificial cerebrospinal fluid; ACx, auditory cortex; AMPARs, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors; Cre-loxP, cyclization recombinase- locus of X(cross)-over in P1; DAPI, 4′,6-diamidino-2-phenylindole; DNQX, 6,7-dinitroquinoxaline-2, 3-dione; EGFP, enhanced green fluorescent protein; EPM, elevated plus maze; EPSC, excitatory postsynaptic currents; EYFP, enhanced yellow fluorescent protein; Flp-FRT, flippase recombination enzyme-flp recognition target; GABA, gamma-aminobutyric acid; GABAARs, gamma-aminobutyric acid type A receptors; Glu, glutamate; IPSCs, inhibitory postsynaptic currents; LA, lateral amygdala; MG, medial geniculate body; SEM, standard error of the mean; VH, holding potential.
Figure 4A is schematic diagram depicting the viral injection for retrograde tracing, including adeno-associated virus per retro enhanced green fluorescent protein, auditory cortex, medial geniculate body, and lateral amygdala. Figure 4B is a virally infected tissue that depicts the successful viral injection in the amygdala, lateral amygdala, and basolateral amygdala. Figure 4C is a schematic diagram depicting the retrogradely traced neurons in the auditory thalamus in the medial geniculate body. Figures 4D and 4G are stained tissues that display cell type identification of traced enhanced green fluorescent protein-positive medial geniculate body neurons, where the most traced neurons were immunoreactive to antibodies against glutamate but none to antibodies against gamma-aminobutyric acid. Figures 4E, 4H, 4L, 4Q are bar graphs, cell (percentage), ranging from 0 to 100 in increments of 20; cell (percentage), ranging from 0 to 100 in increments of 20; cell (percentage), ranging from 0 to 100 in increments of 20; light-evoked excitatory postsynaptic currents (nanoampere), ranging from 0.0 to 1.5 in increments of 0.5 (y-axis) across glutamate and gamma-aminobutyric acid; glutamate and gamma-aminobutyric acid; glutamate and gamma-aminobutyric acid, each under enhanced green fluorescent protein and mCherry; and medial geniculate body with lateral amygdala and auditory cortex with lateral amygdala (x-axis). Figure 4I is a schematic diagram depicting the tracing strategy using a cyclization recombinase- locus of X(cross)-over in P 1) system to dissect the auditory cortex with lateral amygdala circuit and an flippase recombination enzyme-flp recognition target system to dissect the medial geniculate body with lateral amygdala circuit. Figure 4J is a virally traced tissue displays depicting the images of anterogradely traced lateral amygdala neurons in the enhanced yellow fluorescent protein postsynaptic to medial geniculate body projection fibers and those in mCherry postsynaptic to auditory cortex fibers. Figure 4K is a stained tissue depicting the images that displays predominant co-localization of traced fluorescent neurons with glutamate immunofluorescence signals, but few co-localization with gamma-aminobutyric acid immunofluorescence signals in the lateral amygdala. Figure 4M is a schematic diagram depicting the whole-cell recordings combined with optogenetics with adeno-associated virus-calmodulin-dependent protein kinase 2-channelrhodopsin-2-mCherry and 473 nanometers of light in the lateral amygdala with medial geniculate body fibers expressing channelrhodopsin-2. Figure 4N displays sample traces of action potentials in current-clamp mode with 50 millivolts in 100 milliseconds and postsynaptic currents in voltage-clamp mode evoked by a series of 473 nanometers of light stimuli in the lateral amygdala with medial geniculate body fibers expressing channelrhodopsin-2. Figure 4O is a schematic diagram depicting the whole-cell recordings combined with optogenetics with adeno-associated virus-calmodulin-dependent protein kinase 2-channelrhodopsin-2-mCherry and 473 nanometers of light in the lateral amygdala with auditory cortex fibers expressing channelrhodopsin-2. Figure 4P displays sample traces of action potentials in current-clamp mode with 50 millivolts in 100 milliseconds and postsynaptic currents in voltage-clamp mode evoked by a series of 473 nanometers light stimuli of auditory cortex fibers within lateral amygdala. Figure 4R is a set of one schematic diagram and one bar graph. The schematic diagram depicts the sample current traces of light-evoked excitatory postsynaptic currents recorded and of light-evoked inhibitory postsynaptic currents recorded by illuminating the medial geniculate body fibers within lateral amygdala. The bar denotes light, and the arrowhead denotes the beginning of light-evoked postsynaptic currents. The bar graph, plotting latency (millisecond), ranging from 0 to 15 in increments of 5 (y-axis) across excitatory postsynaptic currents and inhibitory postsynaptic currents (x-axis). Figure 4S is a set of one schematic diagram and one bar graph. The schematic diagram depicts the sample current traces of light-evoked excitatory postsynaptic currents recorded and of light-evoked inhibitory postsynaptic currents recorded by illuminating the auditory cortex projection fibers within lateral amygdala. The bar denotes light, and the arrowhead denotes the beginning of light-evoked postsynaptic currents. The bar graph, plotting latency (millisecond), ranging from 0 to 15 in increments of 5 (y-axis) across excitatory postsynaptic currents and inhibitory postsynaptic currents (x-axis). Figure 4T is a schematic diagram depicting the delivery of auditory monosynaptic excitation and di-synaptic inhibition to the lateral amygdala, including glutamate, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, gamma-aminobutyric acid, and gamma-aminobutyric acid type A receptors.
Figure 4.
Viral tracing and patch-clamp recording for morphological and functional characterization of auditory inputs to the LA. Retrograde viral tracing at the LA was used to identify auditory brain regions with LA-projecting neurons, and anterograde viral tracing at these auditory nuclei was performed to morphologically confirm the connections; functional synapses were examined using electrophysiological recordings and optogenetic stimulation in brain slices. (A) Schematic of viral injection for retrograde tracing. (B) Representative image of a successful viral injection in the LA. Scale bars: 500μm. (C) Retrogradely traced neurons in the auditory thalamus. Scale bars: 500μm. (D) Cell type identification of traced EGFP-positive MG neurons; most traced neurons were immunoreactive to antibody against glutamate (top) but none to antibody against GABA (bottom). Scale bars: 20μm. (E) The percentage of glutamate and GABA neurons among the traced EGFP-positive MG neurons. (F) The retrogradely traced neurons in the temporal regions. Scale bars: 500μm. (G) Cell type identification of traced EGFP-positive ACx neurons; most traced neurons were immunoreactive to the antibody for glutamate (top) but few to the antibody for GABA (bottom). Scale bars: 20μm. (H) The percentage of glutamate-positive and GABA-positive neurons among the traced EGFP-positive ACx neurons. (I) Tracing strategy using a Cre-loxP system to dissect the ACxLA circuit and an Flp-FRT system to dissect the MGLA circuit. (J) Representative images of anterogradely traced LA neurons (green, EYFP) postsynaptic to MG projection fibers and those (red, mCherry) postsynaptic to ACx fibers. Scale bars: 100μm. (K) Typical images showing predominant co-localization of traced fluorescent neurons with glutamate immunofluorescence signals but few co-localizations with GABA immunofluorescence signals in the LA. Scale bars: 20μm. (L) The percentage of EYFP-positive cells or mCherry-positive cells containing glutamate or GABA in the LA. (M) Schematic for whole-cell recordings combined with optogenetics. (N) Sample traces of action potentials (top, current-clamp mode) and postsynaptic currents (bottom, voltage-clamp mode) evoked by a series of 473 nm light (blue bars) stimuli of MGLA fibers. (O) Schematic for whole-cell recordings combined with optogenetics. (P) Sample traces of action potentials (top, current-clamp mode) and postsynaptic currents (bottom, voltage-clamp mode) evoked by a series of 473 nm light (blue bars) stimuli of ACxLA fibers. (Q) Quantification of light-evoked EPSCs. (R) Sample current traces of light-evoked EPSCs recorded at a holding potential of 70 mV and of light-evoked IPSCs recorded at a holding potential of 0 mV by illuminating MGLA fibers (left), and quantification of the latency for light-evoked EPSCs and IPSCs (right, t(18)=19.03, p<0.0001). The blue bar denotes 473 nm light, and the arrowhead denotes the beginning of light-evoked postsynaptic currents. (S) Sample current traces of light-evoked EPSCs recorded at a holding potential of 70 mV and of light-evoked IPSCs recorded at a holding potential of 0 mV (left) generated by illuminating ACxLA projection fibers, and quantification of the latency of light-evoked EPSCs and IPSCs (right, t(18)=9.504, p<0.0001). The blue bar denotes 473 nm light, and the arrowhead denotes the beginning of light-evoked postsynaptic currents. (T) Schematic diagram showing delivery of auditory monosynaptic excitation and di-synaptic inhibition to the LA. The data are expressed as the mean±SEM. ***p<0.001. Unpaired Student’s t-test for (R) and (S). For (E) n=5 slices from 3 mice (glutamate), 6 slices from 3 mice (GABA). For (H) n=10 slices from 3 mice (glutamate), 9 slices from 3 mice (GABA). For (L) n=6 slices from 3 mice (EGFP+ and glutamate+), 6 slices from 3 mice (EYFP+ and GABA+), 6 slices from 3 mice (mCherry+ and glutamate+), 6 slices from 3 mice (mCherry+ and GABA+). For (Q) n=14 cells (MGLA), 14 cells (ACxLA). For (R) n=10 cells (EPSC), 10 cells (IPSC). For (S) n=10 cells (EPSC), 10 cells (IPSC). The numerical data underlying this figure are shown in Excel Tables S3–S4. Note: AAV, adeno-associated virus; ACSF, artificial cerebrospinal fluid; ACx, auditory cortex; AMPARs, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors; Cre-loxP, cyclization recombinase- locus of X(cross)-over in P1; DAPI, 4′,6-diamidino-2-phenylindole; DNQX, 6,7-dinitroquinoxaline-2, 3-dione; EGFP, enhanced green fluorescent protein; EPM, elevated plus maze; EPSC, excitatory postsynaptic currents; EYFP, enhanced yellow fluorescent protein; Flp-FRT, flippase recombination enzyme-flp recognition target; GABA, gamma-aminobutyric acid; GABAARs, gamma-aminobutyric acid type A receptors; Glu, glutamate; IPSCs, inhibitory postsynaptic currents; LA, lateral amygdala; MG, medial geniculate body; SEM, standard error of the mean; VH, holding potential.
Figure 5A is a schematic diagram depicting the viral injection and optogenetics with the adeno-associated virus-calmodulin-dependent protein kinase 2-channelrhodopsin-2-mCherry-expressing medial geniculate body fibers within lateral amygdala and 473 nanometers of light Figure 5B is a stained tissue that displays the typical images of the viral injection in the medial geniculate body and an optical fiber track above the lateral amygdala with channelrhodopsin-2-expressing medial geniculate body fibers. Figures 5C, 5D, 5G, and 5H are clustered bar graphs, plotting time in center, ranging from 0 to 60 in increments of 20; time in open arms (second), ranging from 0 to 150 in increments of 50; time in center (second), ranging from 0 to 60 in increments of 20; and time in open arms (second), ranging from 0 to 150 in increments of 50 (y-axis) across mCherry and channelrhodopsin-2 (x-axis). Figure 5I is a timeline depicting the chemogenetic experiments including adeno-associated virus-calmodulin-dependent protein kinase 2-channelrhodopsin-2-mCherry-expressing lateral amygdala, medial geniculate, clozapine-N-oxide, auditory cortex. Between days 0 and 1, habituation was conducted. Between days 1 and 28, noise exposure was conducted. From day 14, daily clozapine-N-oxide injections were started. From day 28, open field tests or elevated plus mazes began. Figures 5J, 5K, and 5L are bar graphs, plotting time in center (second), ranging from 0 to 50 in increments of 10; total distance (centimeter), ranging from 0 to 4000 in increments of 1000; time in open arms (second), ranging from 0 to 120 in increments of 40 (y-axis) across mCherry and human M4 muscarinic receptor (x-axis).
Figure 5.
Behavioral effects of optogenetic activation or chemogenetic inactivation of auditory inputs to the LA. Optogenetic activation was used to selectively excite auditory inputs to the LA to determine whether activating these inputs could mimic noise-evoked anxiety-like behaviors. Chemogenetic blocking was used to selectively silence auditory inputs to the LA during noise exposure to determine whether they were necessary for noise-evoked anxiety-like behavior. (A) Schematic for viral injection and optogenetics. (B) Typical images of the viral injection in the MG (left) and optical fiber track above the LA with ChR2-expressing MG fibers (right). Scale bars: 200μm. (C and D) Summarized data for time spent in the center of OFT (C, virus×light interaction, F(1,20)=52.22, p<0.0001; main effect of light, F(1,20)=32.65, p<0.0001) and time in the open arms of the EPM (D, virus×light interaction, F(1,20)=25.67, p<0.0001; main effect of light, F(1,20)=23.41, p<0.0001) before (pre) and during (light) light stimulation of MGLA fibers. (E) Schematic for viral injection and optogenetics. (F) Typical images of viral injection in the ACx (left) and optical fiber track above the LA with ChR2-experssing ACx fibers (right). Scale bars: 200μm. (G and H) Summarized data for time spent in the center of OFT (G, virus×light interaction, F(1,22)=64.09, p<0.0001; main effect of light, F(1,22)=36.02, p<0.0001) and time in the open arms of the EPM (H, virus×light interaction, F(1,18)=27.47, p<0.0001; main effect of light, F(1,18)=32.77, p<0.0001) before (pre) and during (light) light stimulation of ACxLA fibers. (I) Timeline for chemogenetic experiments. (J–L) Summarized data for time spent in the center (J, t(14)=8.097, p<0.0001) and total distance traveled (K, t(14)=0.7899, p=0.4427) in the OFT and time in the open arms of EPM (L, t(14)=4.386, p=0.0006). The data are expressed as the mean±SEM. ***p<0.001. Two-way ANOVA with Bonferroni post hoc analysis for (C), (D), (G), and (H). Unpaired t-test for (J), (K), and (L). For (C) n=10 mCherry mice, 12 ChR2 mice. For (D) n=10 mCherry mice, 12 ChR2 mice. For (G) n=12 mCherry mice, 12 ChR2 mice. For (H) n=10 mCherry mice, 10 ChR2 mice. For (J) n=8 mCherry mice, 8 hM4Di mice. For (K) n=8 mCherry mice, 8 hM4Di mice. For (L) n=8 mCherry mice, 8 hM4Di mice. The numerical data underlying this figure are shown in Excel Tables S1. Note: AAV, adeno-associated virus; ACx, auditory cortex; ANOVA, analysis of variance; CaM, calcium-calmodulin; CaMKII, CaM-dependent protein kinase II; ChR2, channelrhodopsin-2; CNO, clozapine-N-oxide; EPM, elevated plus maze; hM4, human M4 muscarinic; hM4Di, human M4 muscarinic receptor; LA, lateral amygdala; MG, medial geniculate body; NS, not significant; OFT, open-field tests; Pre, before light stimulation; SEM, standard error of the mean.
Figure 6A is a timeline of the experimental protocol. In the beginning, four weeks of noise exposure were conducted. From week 4 to 8, it was a recovery period. From week 8 on, behavioral tests were conducted, including 2 hours and 85 decibels of sound pressure level noise. Figures 6B, 6C, 6E are clustered bar graphs, plotting time in center (second), ranging from 0 to 80 in increments of 20; time in open arms (second), ranging from 0 to 100 in increments of 20; firing rate (hertz), ranging from 0 to 8 in increments of 2 (y-axis) across eighth week and 2 hours and 85 decibels of sound pressure level (x-axis) for control and noise. Figure 6D is a representative image of the voltage traces of spontaneous firings recorded in the lateral amygdala during the eighth week and 2 hours and 85 decibels of sound pressure level with 100 microvolts in 100 milliseconds. Figures 6F and 6G is a bar graph, plotting time in center (second), ranging from 0 to 60 in increments of 20 and time in open arms (second), ranging from 0 to 60 in increments of 20 (y-axis) across control and noise (x-axis) for 2 hours and 75 decibels of sound pressure level noise.
Figure 6.
Experimental overview, behavior, and electrophysiological effects of acute noise exposure in mice after 4 wk of noise withdrawal. All chronic noise-exposed mice or control were subjected to 4-wk noise withdrawal, and then their behaviors were tested before and after 2-h noise exposure to examine their susceptibility to acute noise exposure. Anxiety-like behaviors and elevated spontaneous neuronal firing in the LA were observed. (A) Timeline of the experimental protocol. (B and C) Summarized data for the time in the center of OFT (B, 8W, U=17, p=0.1806; 2-h 85 dB SPL, U=0, p=0.0002) and time in the open arms of EPM (C, time×noise interaction, F(1,14)=10.47, p=0.0060; main effect of noise, F(1,14)=10.99, p=0.0051) at the indicated time points. (D and E) Representative voltage traces of spontaneous firings recorded in the LA (D) and summarized data (E, time×noise interaction, F(1,64)=4.401, p=0.0399; main effect of noise, F(1,64)=6.415, p=0.0138). (F and G) Summarized data for time spent in the center of the OFT (F, t(10)=4.015, p=0.0025), and time in the open arms of the EPM (G, t(10)=2.890, p=0.0161) in recovered mice reexposed to 2-h 75 dB SPL noise. The data are expressed as the mean±SEM. *p<0.05; **p<0.01; ***p<0.001. Mann-Whitney U-test for (B). Two-way ANOVA with Bonferroni post hoc analysis for (C) and (E). Unpaired Student’s t-test for (F) and (G). For (B) n=6 control mice, 10 noise mice. For (C) n=6 control mice, 10 noise mice. For (E) n=16 cells (8W control), 17 cells (8W noise), 15 cells (2h 85 dB control), 20 cells (2h 85 dB noise). For (F) n=5 control mice, 7 noise mice. For (G) n=5 control mice, 7 noise mice. The numerical data underlying this figure are shown in Excel Tables S1–2. Note: 8W, eighth week; ANOVA, analysis of variance; dB SPL, decibel sound pressure level; EPM, elevated plus maze; LA, lateral amygdala; OFT, open-field tests; SEM, standard error of the mean.

References

    1. Takacs JD, Forrest TJ, Basura GJ. 2017. Noise exposure alters long-term neural firing rates and synchrony in primary auditory and rostral belt cortices following bimodal stimulation. Hear Res 356:1–15, PMID: , 10.1016/j.heares.2017.07.004. - DOI - PubMed
    1. Basner M, Babisch W, Davis A, Brink M, Clark C, Janssen S, et al. . 2014. Auditory and non-auditory effects of noise on health. Lancet 383(9925):1325–1332, PMID: , 10.1016/S0140-6736(13)61613-X. - DOI - PMC - PubMed
    1. Kraus KS, Canlon B. 2012. Neuronal connectivity and interactions between the auditory and limbic systems. Effects of noise and tinnitus. Hear Res 288(1–2):34–46, PMID: , 10.1016/j.heares.2012.02.009. - DOI - PubMed
    1. Jafari Z, Kolb BE, Mohajerani MH. 2018. Chronic traffic noise stress accelerates brain impairment and cognitive decline in mice. Exp Neurol 308:1–12, PMID: , 10.1016/j.expneurol.2018.06.011. - DOI - PubMed
    1. Hayes SH, Manohar S, Majumdar A, Allman BL, Salvi R. 2019. Noise-induced hearing loss alters hippocampal glucocorticoid receptor expression in rats. Hear Res 379:43–51, PMID: , 10.1016/j.heares.2019.04.013. - DOI - PMC - PubMed

Publication types